Advanced functional nanomaterials for precise cancer diagnosis - nanoCANdi
Project summary
NanoCANdi develops new functional materials and biosensing microtechnology for cancer diagnosis. The project designs and manufactures large magnetic moment nanostructures with unique spin configurations for biomedical applications, specifically optimized for ultra-high sensitive giant magnetoresistance biosensors by micromagnetic modelling of both nanostructures and sensors. It addresses a key strategy in the fight against cancer: the early-stage detection of the disease. A crucial feature in this strategy is the specific biorecognition of cancer indicators. NanoCANdi undertakes this key point creating exclusive aptamers for a precise immobilization of cancer biomarkers, developing an innovative aptakiss/aptaswitch selection approach. The project expands new technologies and materials, producing biosensing devices that will impact the healthcare system with the adoption of precise medicine, letting physicians to detect and monitor treatments with reliable and affordable biochips.Project Details
Call
Call 2022
Call Topic
Functional materials
Project start
01.10.2023
Project end
30.09.2026
Total project costs
872.172 €
Total project funding
685.922 €
TRL
2 - 5
Coordinator
Prof. Rafael Morales
rafael.morales@ehu.es
UPV/EHU, BARRIO SARRIENA S N, 48940 LEIOA, Spain
Partners and Funders Details
Consortium Partner | Country | Funder | |
---|---|---|---|
UPV/EHU https://www.ehu.eus |
University | Spain | ES-AEI |
IMG Pharma https://www.imgpharma.com |
SME | Spain | ES-EJ-GV/Innobasque |
INSERM https://arna.cnrs.fr/ |
Research org. | France | FR-ANR |
CSIC https://www.csic.es |
Research org. | Spain | ES-AEI |
UNICAMP https://www.unicamp.br |
University | Brazil | BR-FAPESP |